Q&A with Adam Sanford, Director of Business Development, East

Who are you?

“My name is Adam, and I am the new Director of Business Development for the East Coast at Oligo Factory. I’m thrilled to be on board!”

What will you be doing in your new role?

“I will be responsible for helping our current customers and partners understand how we can serve them better and assist with their oligo production needs. Additionally, I will be working with potential new clients to show them how we can improve the speed, purity, and reliability of the oligos they need to achieve their goals.”

What excites you about working at Oligo Factory?

“The people who work here are what excite me the most. During the interview process, it was evident that the entire team, from the scientists to the leadership to the Board, was united in their goal to make our products the best they can be while maintaining a positive and inclusive work environment. I’m thrilled to be working with such a great group of people.”

What do you love about working in biotech?

“Contributing to cutting-edge research that saves lives and improves quality of life around the world is what drew me to science in the first place. While I may not be doing benchtop work anymore, I still see my role as supporting these goals and the people doing this work. Helping my clients achieve their research goals is what motivates me to come to work every day.”

What are you and the rest of the team hoping to achieve?

“The oligo market is currently underserved, with demand for production far exceeding supply. Unreliable synthesis timelines are also causing delays in bringing life-saving medicines to clinical trials and the public. While we may not be a household name yet, we’ve been in this business for over fifteen years and are ready to show everyone that there’s a better way to get custom oligos made at scale. We’re committed to growing our business and ensuring that we meet the needs of our clients in a timely manner while maintaining the highest standards of purity and quality.”